HUP0402639A3 - Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its use - Google Patents
Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its useInfo
- Publication number
- HUP0402639A3 HUP0402639A3 HU0402639A HUP0402639A HUP0402639A3 HU P0402639 A3 HUP0402639 A3 HU P0402639A3 HU 0402639 A HU0402639 A HU 0402639A HU P0402639 A HUP0402639 A HU P0402639A HU P0402639 A3 HUP0402639 A3 HU P0402639A3
- Authority
- HU
- Hungary
- Prior art keywords
- serine
- inhibitors
- kinase
- distamycin derivatives
- protein kinase
- Prior art date
Links
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 title 1
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 title 1
- -1 acryloyl distamycin derivatives Chemical class 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108060006633 protein kinase Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075052 | 2002-01-02 | ||
| PCT/EP2002/013092 WO2003055522A1 (en) | 2002-01-02 | 2002-12-18 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0402639A2 HUP0402639A2 (hu) | 2005-04-28 |
| HUP0402639A3 true HUP0402639A3 (en) | 2012-02-28 |
Family
ID=8185508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402639A HUP0402639A3 (en) | 2002-01-02 | 2002-12-18 | Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its use |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20060084612A1 (hu) |
| EP (1) | EP1461083B1 (hu) |
| JP (1) | JP2005516025A (hu) |
| KR (1) | KR20040078118A (hu) |
| CN (1) | CN1617744A (hu) |
| AT (1) | ATE321572T1 (hu) |
| AU (1) | AU2002352090B8 (hu) |
| BR (1) | BR0215454A (hu) |
| CA (1) | CA2472008C (hu) |
| CY (1) | CY1105269T1 (hu) |
| DE (1) | DE60210329T2 (hu) |
| DK (1) | DK1461083T3 (hu) |
| ES (1) | ES2263835T3 (hu) |
| HU (1) | HUP0402639A3 (hu) |
| IL (2) | IL162820A0 (hu) |
| MX (1) | MXPA04006543A (hu) |
| NO (1) | NO20043217L (hu) |
| NZ (1) | NZ533854A (hu) |
| PL (1) | PL371179A1 (hu) |
| PT (1) | PT1461083E (hu) |
| RU (1) | RU2328306C2 (hu) |
| SI (1) | SI1461083T1 (hu) |
| WO (1) | WO2003055522A1 (hu) |
| ZA (1) | ZA200405290B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| PT1545553E (pt) * | 2002-07-30 | 2011-09-12 | Aeterna Zentaris Gmbh | Utilização de alquilfosfocolinas em combinação com medicamentos antitumorais |
| WO2006108763A1 (en) * | 2005-04-08 | 2006-10-19 | Nerviano Medical Sciences S.R.L. | Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors |
| MX2011011596A (es) | 2010-03-31 | 2012-02-01 | Keryx Biopharmaceuticals Inc | Perifosina y capecitabina como un tratamiento combinado para cancer. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274576B1 (en) * | 1995-06-27 | 2001-08-14 | The Henry Jackson Foundation For The Advancement Of Military Medicine | Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| GB9615692D0 (en) * | 1996-07-25 | 1996-09-04 | Pharmacia Spa | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| GB0015447D0 (en) * | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents |
| GB0015444D0 (en) * | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors |
-
2002
- 2002-12-18 MX MXPA04006543A patent/MXPA04006543A/es active IP Right Grant
- 2002-12-18 CN CNA028276744A patent/CN1617744A/zh active Pending
- 2002-12-18 WO PCT/EP2002/013092 patent/WO2003055522A1/en active IP Right Grant
- 2002-12-18 BR BR0215454-4A patent/BR0215454A/pt not_active IP Right Cessation
- 2002-12-18 NZ NZ533854A patent/NZ533854A/en not_active IP Right Cessation
- 2002-12-18 SI SI200230335T patent/SI1461083T1/sl unknown
- 2002-12-18 EP EP02787763A patent/EP1461083B1/en not_active Expired - Lifetime
- 2002-12-18 AT AT02787763T patent/ATE321572T1/de active
- 2002-12-18 PT PT02787763T patent/PT1461083E/pt unknown
- 2002-12-18 IL IL16282002A patent/IL162820A0/xx unknown
- 2002-12-18 DK DK02787763T patent/DK1461083T3/da active
- 2002-12-18 DE DE60210329T patent/DE60210329T2/de not_active Expired - Lifetime
- 2002-12-18 RU RU2004123641/15A patent/RU2328306C2/ru not_active IP Right Cessation
- 2002-12-18 AU AU2002352090A patent/AU2002352090B8/en not_active Ceased
- 2002-12-18 ES ES02787763T patent/ES2263835T3/es not_active Expired - Lifetime
- 2002-12-18 HU HU0402639A patent/HUP0402639A3/hu unknown
- 2002-12-18 US US10/500,606 patent/US20060084612A1/en not_active Abandoned
- 2002-12-18 KR KR10-2004-7010472A patent/KR20040078118A/ko not_active Application Discontinuation
- 2002-12-18 JP JP2003556098A patent/JP2005516025A/ja active Pending
- 2002-12-18 CA CA002472008A patent/CA2472008C/en not_active Expired - Fee Related
- 2002-12-18 PL PL02371179A patent/PL371179A1/xx not_active Application Discontinuation
-
2004
- 2004-07-01 IL IL162820A patent/IL162820A/en not_active IP Right Cessation
- 2004-07-02 ZA ZA200405290A patent/ZA200405290B/xx unknown
- 2004-07-29 NO NO20043217A patent/NO20043217L/no not_active Application Discontinuation
-
2006
- 2006-06-05 CY CY20061100717T patent/CY1105269T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1617744A (zh) | 2005-05-18 |
| KR20040078118A (ko) | 2004-09-08 |
| RU2328306C2 (ru) | 2008-07-10 |
| WO2003055522A1 (en) | 2003-07-10 |
| DK1461083T3 (da) | 2006-07-10 |
| DE60210329D1 (de) | 2006-05-18 |
| RU2004123641A (ru) | 2005-06-10 |
| AU2002352090B8 (en) | 2008-06-19 |
| SI1461083T1 (sl) | 2006-08-31 |
| IL162820A (en) | 2010-04-15 |
| EP1461083B1 (en) | 2006-03-29 |
| ZA200405290B (en) | 2005-06-17 |
| PT1461083E (pt) | 2006-08-31 |
| CA2472008C (en) | 2009-07-28 |
| AU2002352090A1 (en) | 2003-07-15 |
| ES2263835T3 (es) | 2006-12-16 |
| NO20043217L (no) | 2004-07-30 |
| DE60210329T2 (de) | 2006-11-30 |
| IL162820A0 (en) | 2005-11-20 |
| JP2005516025A (ja) | 2005-06-02 |
| MXPA04006543A (es) | 2004-10-04 |
| CY1105269T1 (el) | 2010-03-03 |
| BR0215454A (pt) | 2004-11-23 |
| US20060084612A1 (en) | 2006-04-20 |
| HUP0402639A2 (hu) | 2005-04-28 |
| EP1461083A1 (en) | 2004-09-29 |
| NZ533854A (en) | 2007-05-31 |
| PL371179A1 (en) | 2005-06-13 |
| AU2002352090B2 (en) | 2008-05-15 |
| ATE321572T1 (de) | 2006-04-15 |
| CA2472008A1 (en) | 2003-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL376789A1 (pl) | Pochodne aminoindazoli i ich zastosowanie jako inhibitorów kinazy | |
| PL375447A1 (en) | Protein kinase inhibitors and uses thereof | |
| IL176233A0 (en) | Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors | |
| AU2003259749A1 (en) | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors | |
| PL1648426T3 (pl) | Pochodne benzimidazolu i ich zastosowanie jako inhibitorów kinaz białkowych | |
| IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
| AU2003299651A1 (en) | Tyrosine kinase inhibitors | |
| IL182428A0 (en) | Indolylmaleimide derivatives as protein kinase c inhibitors | |
| HK1061854A1 (en) | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
| PL370575A1 (en) | 5-phenylthiazole derivatives and use as pi3 kinase inhibitors | |
| HK1079518A1 (en) | Quinazolinone derivatives and their use as cb agonists | |
| AU2003298942A1 (en) | Tyrosine kinase inhibitors | |
| EP1534268A4 (en) | TYROSINE KINASE INHIBITORS | |
| AU2002953255A0 (en) | Protein kinase inhibitors | |
| AU2003220437A1 (en) | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors | |
| PL374581A1 (en) | Diaminothiazoles and use thereof as cdk4 inhibitors | |
| EP1496897A4 (en) | INHIBITORS OF TYROSINE KINASES | |
| AU2003210983A1 (en) | Kinase inhibitors and methods of use thereof | |
| AP1963A (en) | Substituted pyrrole derivatives and their use as HMG-co inhibitors | |
| AUPS251502A0 (en) | Protein kinase inhibitors | |
| AU2003268464A8 (en) | Indole-type derivatives as inhibitors of p38 kinase | |
| HUP0402639A3 (en) | Antitumor combination comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors and its use | |
| GB0511267D0 (en) | Indol derivatives and their use as kinase inhibitors | |
| AU2003278250B2 (en) | Aminoindazole derivatives and use thereof as kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: NERVIANO MEDICAL SCIENCES S.R.L., IT Free format text: FORMER OWNER(S): PHARMACIA ITALIA S.P.A., IT |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |